NCT05188612 International Survey of Acute Coronavirus Syndromes-COVID-19
| NCT ID | NCT05188612 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bologna |
| Condition | COVID-19 |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2021-12-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2021-12-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In response to the COVID-19 crisis, ISACS-TC has promoted a new registry of the existing and further centers of the same geographic areas to support clinical research to prevent, and treat the COVID-19 illness. These efforts are made possible by the generous contributions of clinical research volunteers in some of the countries participating to the prior acute coronary syndrome network.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years (male or female) * Patients admitted to any hospital center with a confirmed diagnosis of COVID-19 infection. Exclusion Criteria: • Underage or not able to give informed consent
Contact & Investigator
Olivia Manfrini, MD
STUDY DIRECTOR
University of Bologna
Frequently Asked Questions
Who can join the NCT05188612 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COVID-19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05188612 currently recruiting?
Yes, NCT05188612 is actively recruiting participants. Contact the research team at raffaele.bugiardini@unibo.it for enrollment information.
Where is the NCT05188612 trial being conducted?
This trial is being conducted at Bologna, Italy, Barcelona, Spain.
Who is sponsoring the NCT05188612 clinical trial?
NCT05188612 is sponsored by University of Bologna. The principal investigator is Olivia Manfrini, MD at University of Bologna. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.